Outset Medical, Inc. (OM)
| Previous close | 3.7900 |
| Open | 3.8000 |
| Bid | 3.6300 x 300 |
| Ask | 3.6800 x 100 |
| Day's range | 3.5700 - 3.9700 |
| 52-week range | 1.9200 - 24.1300 |
| Volume | |
| Avg. volume | 1,219,321 |
| Market cap | 189.747M |
| Beta (5Y monthly) | 1.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
SAN JOSE, Calif., May 06, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of TabloCartTM with prefiltration, an innovative optional accessory for the Tablo® Hemodialysis System.
- Business Wire
Outset Medical to Present at Upcoming Investor Conferences
SAN JOSE, Calif., May 01, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the BofA Securities Health Care conference on Tuesday, May 14, 2024 at 2:20 p.m. Eastern time/11:20 a.m. Pacific time, and at the RBC Capital Markets Global Health Care conference on Wednesday, May 15, 2024 at 1:35 p.m. Eastern time/10:35 a.
- Business Wire
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
SAN JOSE, Calif., April 19, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.
